Skip to content ⤶ Skip to footer ⤶

Supporting those receiving immunotherapy by supporting those delivering it

IOCN Support health care professionals delivering immuno-oncology therapies to improve patient care through clinical support, education, service development and governance

Pillar 1

Education and Training

Providing education and training opportunities in Immuno-Oncology therapeutics and the autoimmune side effects.

Read More

Pillar 2

Clinical Support

Uniting experts in the field of Immuno- Oncology to disseminate clinical knowledge and experience to the broader oncology community.

Read More

Pillar 3

Service Development

Helping healthcare professionals develop services with a focus on managing of the auto-immune side effects.

Read More

Pillar 4

Research and Analysis

Promotion and support research or any activities that will progress our knowledge of immuno-oncology treatments and the auto-immune side effects.

Read More

Pillar 5

Policy and Governance

Collaborating with organisations and charities to support healthcare professionals develop Immuno- oncology policies and governance strategies.

Read More

    Webinars and upcoming events

    Find out more about the IOCN future educational events.

    See all events

    What we do

    The Immuno-Oncology Clinical Network (IOCN) is a charity that strives to improve the care of cancer patients receiving immuno-oncological (IO) treatments. We do this through supporting healthcare professionals by providing education and clinical support alongside support with key policy and governance subjects around IO treatments, research and service development.

    Continue Reading

    About us

    The Immuno-Oncology Clinical Network was established in 2022 by Dr Anna Olsson-Brown and a team of trustees with a passion for improving the care of cancer patients receiving immunotherapy treatment.

    Education and Training

    The IOCN team is passionate about providing education and training to healthcare professionals on all aspects of immune-oncology (IO) treatments, including the recognition and management of immune-mediated side effects. We provide healthcare professionals with a variety of educational offerings, including in-person events, free webinars, and podcasts.

    Join us

    Become a member of the IOCN to connect with a network of healthcare professionals and gain access to exclusive content, including educational events, free webinars, the latest news, and more.

    The Immunobuddies Podcast

    Ricky Frazer and Anna Olsson-Brown with guests discuss the dilemmas, challenges and progress made in the management of patients receiving immunotherapies to treat cancer.

    Upcoming News

    There are 2 posts for you to peruse.

    17.03.25

    Drug Monographs Released by BOPA

    BOPA have released drug monographs for second line immunosupressive agents. 

    17.11.22

    New & Novel: Immune effector cell-associated neurotoxicity syndrome (ICANS)

    Lorem ipsum dolor sit amet, at eos assum mandamus quaerendum, quot assentior cu eam, no vim oratio audiam scaevola. Ea ius iracundia hendrerit, stet iusto ad quo.